nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—SLC22A5—dilated cardiomyopathy	0.752	1	CbGaD
Ipratropium bromide—SLC22A5—Furosemide—dilated cardiomyopathy	0.151	1	CbGbCtD
Ipratropium bromide—Ulcer—Spironolactone—dilated cardiomyopathy	0.00216	0.0404	CcSEcCtD
Ipratropium bromide—Local reaction—Furosemide—dilated cardiomyopathy	0.00201	0.0376	CcSEcCtD
Ipratropium bromide—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.00117	0.0218	CcSEcCtD
Ipratropium bromide—Swelling—Furosemide—dilated cardiomyopathy	0.000916	0.0171	CcSEcCtD
Ipratropium bromide—Thirst—Furosemide—dilated cardiomyopathy	0.000849	0.0159	CcSEcCtD
Ipratropium bromide—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.000811	0.0152	CcSEcCtD
Ipratropium bromide—Wheezing—Lisinopril—dilated cardiomyopathy	0.000811	0.0152	CcSEcCtD
Ipratropium bromide—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.000811	0.0152	CcSEcCtD
Ipratropium bromide—Urinary retention—Furosemide—dilated cardiomyopathy	0.000769	0.0144	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00073	0.0136	CcSEcCtD
Ipratropium bromide—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.000666	0.0124	CcSEcCtD
Ipratropium bromide—Somnolence—Spironolactone—dilated cardiomyopathy	0.000649	0.0121	CcSEcCtD
Ipratropium bromide—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000645	0.0121	CcSEcCtD
Ipratropium bromide—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00064	0.012	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00063	0.0118	CcSEcCtD
Ipratropium bromide—Arthritis—Lisinopril—dilated cardiomyopathy	0.000624	0.0117	CcSEcCtD
Ipratropium bromide—Sweating—Furosemide—dilated cardiomyopathy	0.000597	0.0112	CcSEcCtD
Ipratropium bromide—Urticaria—Spironolactone—dilated cardiomyopathy	0.00058	0.0108	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000552	0.0103	CcSEcCtD
Ipratropium bromide—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000548	0.0102	CcSEcCtD
Ipratropium bromide—Visual impairment—Furosemide—dilated cardiomyopathy	0.000539	0.0101	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000538	0.01	CcSEcCtD
Ipratropium bromide—Asthma—Lisinopril—dilated cardiomyopathy	0.000524	0.00979	CcSEcCtD
Ipratropium bromide—Influenza—Lisinopril—dilated cardiomyopathy	0.000524	0.00979	CcSEcCtD
Ipratropium bromide—Eye disorder—Furosemide—dilated cardiomyopathy	0.000523	0.00976	CcSEcCtD
Ipratropium bromide—Tinnitus—Furosemide—dilated cardiomyopathy	0.000521	0.00974	CcSEcCtD
Ipratropium bromide—Pruritus—Spironolactone—dilated cardiomyopathy	0.000517	0.00965	CcSEcCtD
Ipratropium bromide—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000516	0.00963	CcSEcCtD
Ipratropium bromide—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000505	0.00943	CcSEcCtD
Ipratropium bromide—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000504	0.00942	CcSEcCtD
Ipratropium bromide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.0005	0.00933	CcSEcCtD
Ipratropium bromide—Dysuria—Lisinopril—dilated cardiomyopathy	0.00049	0.00916	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000487	0.0091	CcSEcCtD
Ipratropium bromide—Dizziness—Spironolactone—dilated cardiomyopathy	0.000483	0.00902	CcSEcCtD
Ipratropium bromide—Flatulence—Furosemide—dilated cardiomyopathy	0.00048	0.00896	CcSEcCtD
Ipratropium bromide—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000477	0.0089	CcSEcCtD
Ipratropium bromide—Vomiting—Spironolactone—dilated cardiomyopathy	0.000464	0.00867	CcSEcCtD
Ipratropium bromide—Rash—Spironolactone—dilated cardiomyopathy	0.00046	0.0086	CcSEcCtD
Ipratropium bromide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00046	0.00859	CcSEcCtD
Ipratropium bromide—Vision blurred—Furosemide—dilated cardiomyopathy	0.000459	0.00857	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000458	0.00856	CcSEcCtD
Ipratropium bromide—Headache—Spironolactone—dilated cardiomyopathy	0.000457	0.00854	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000454	0.00849	CcSEcCtD
Ipratropium bromide—Sweating—Lisinopril—dilated cardiomyopathy	0.000448	0.00837	CcSEcCtD
Ipratropium bromide—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000441	0.00823	CcSEcCtD
Ipratropium bromide—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000439	0.00819	CcSEcCtD
Ipratropium bromide—Nausea—Spironolactone—dilated cardiomyopathy	0.000434	0.0081	CcSEcCtD
Ipratropium bromide—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000421	0.00786	CcSEcCtD
Ipratropium bromide—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000416	0.00778	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000414	0.00774	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000412	0.00769	CcSEcCtD
Ipratropium bromide—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000411	0.00768	CcSEcCtD
Ipratropium bromide—Dry mouth—Furosemide—dilated cardiomyopathy	0.000405	0.00757	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000397	0.00742	CcSEcCtD
Ipratropium bromide—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000391	0.00731	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00039	0.00728	CcSEcCtD
Ipratropium bromide—Flushing—Lisinopril—dilated cardiomyopathy	0.000389	0.00727	CcSEcCtD
Ipratropium bromide—Skin disorder—Furosemide—dilated cardiomyopathy	0.000386	0.00721	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000384	0.00717	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000378	0.00706	CcSEcCtD
Ipratropium bromide—Hypotension—Furosemide—dilated cardiomyopathy	0.000371	0.00693	CcSEcCtD
Ipratropium bromide—Flatulence—Lisinopril—dilated cardiomyopathy	0.00036	0.00672	CcSEcCtD
Ipratropium bromide—Tension—Lisinopril—dilated cardiomyopathy	0.000358	0.00669	CcSEcCtD
Ipratropium bromide—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000358	0.00668	CcSEcCtD
Ipratropium bromide—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000357	0.00666	CcSEcCtD
Ipratropium bromide—Nervousness—Lisinopril—dilated cardiomyopathy	0.000355	0.00663	CcSEcCtD
Ipratropium bromide—Back pain—Lisinopril—dilated cardiomyopathy	0.000353	0.0066	CcSEcCtD
Ipratropium bromide—Somnolence—Furosemide—dilated cardiomyopathy	0.000353	0.0066	CcSEcCtD
Ipratropium bromide—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000344	0.00643	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000343	0.00641	CcSEcCtD
Ipratropium bromide—Fatigue—Furosemide—dilated cardiomyopathy	0.000343	0.0064	CcSEcCtD
Ipratropium bromide—Tremor—Lisinopril—dilated cardiomyopathy	0.000342	0.00639	CcSEcCtD
Ipratropium bromide—Constipation—Furosemide—dilated cardiomyopathy	0.00034	0.00635	CcSEcCtD
Ipratropium bromide—Pain—Furosemide—dilated cardiomyopathy	0.00034	0.00635	CcSEcCtD
Ipratropium bromide—Angioedema—Lisinopril—dilated cardiomyopathy	0.000334	0.00623	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000325	0.00607	CcSEcCtD
Ipratropium bromide—Palpitations—Lisinopril—dilated cardiomyopathy	0.000323	0.00603	CcSEcCtD
Ipratropium bromide—Cough—Lisinopril—dilated cardiomyopathy	0.000319	0.00595	CcSEcCtD
Ipratropium bromide—Urticaria—Furosemide—dilated cardiomyopathy	0.000316	0.00589	CcSEcCtD
Ipratropium bromide—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000314	0.00587	CcSEcCtD
Ipratropium bromide—Chest pain—Lisinopril—dilated cardiomyopathy	0.000311	0.00581	CcSEcCtD
Ipratropium bromide—Myalgia—Lisinopril—dilated cardiomyopathy	0.000311	0.00581	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000309	0.00577	CcSEcCtD
Ipratropium bromide—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000304	0.00568	CcSEcCtD
Ipratropium bromide—Oedema—Lisinopril—dilated cardiomyopathy	0.000298	0.00557	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000298	0.00557	CcSEcCtD
Ipratropium bromide—Infection—Lisinopril—dilated cardiomyopathy	0.000296	0.00553	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000293	0.00547	CcSEcCtD
Ipratropium bromide—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000291	0.00543	CcSEcCtD
Ipratropium bromide—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00029	0.00541	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000288	0.00538	CcSEcCtD
Ipratropium bromide—Asthenia—Furosemide—dilated cardiomyopathy	0.000285	0.00532	CcSEcCtD
Ipratropium bromide—Pruritus—Furosemide—dilated cardiomyopathy	0.000281	0.00525	CcSEcCtD
Ipratropium bromide—Hypotension—Lisinopril—dilated cardiomyopathy	0.000279	0.0052	CcSEcCtD
Ipratropium bromide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000272	0.00508	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000272	0.00507	CcSEcCtD
Ipratropium bromide—Insomnia—Lisinopril—dilated cardiomyopathy	0.00027	0.00504	CcSEcCtD
Ipratropium bromide—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000268	0.005	CcSEcCtD
Ipratropium bromide—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000266	0.00496	CcSEcCtD
Ipratropium bromide—Somnolence—Lisinopril—dilated cardiomyopathy	0.000265	0.00495	CcSEcCtD
Ipratropium bromide—Dizziness—Furosemide—dilated cardiomyopathy	0.000263	0.00491	CcSEcCtD
Ipratropium bromide—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000262	0.0049	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000257	0.00481	CcSEcCtD
Ipratropium bromide—Fatigue—Lisinopril—dilated cardiomyopathy	0.000257	0.0048	CcSEcCtD
Ipratropium bromide—Pain—Lisinopril—dilated cardiomyopathy	0.000255	0.00476	CcSEcCtD
Ipratropium bromide—Constipation—Lisinopril—dilated cardiomyopathy	0.000255	0.00476	CcSEcCtD
Ipratropium bromide—Vomiting—Furosemide—dilated cardiomyopathy	0.000253	0.00472	CcSEcCtD
Ipratropium bromide—Rash—Furosemide—dilated cardiomyopathy	0.000251	0.00468	CcSEcCtD
Ipratropium bromide—Dermatitis—Furosemide—dilated cardiomyopathy	0.00025	0.00467	CcSEcCtD
Ipratropium bromide—Headache—Furosemide—dilated cardiomyopathy	0.000249	0.00465	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000244	0.00455	CcSEcCtD
Ipratropium bromide—Urticaria—Lisinopril—dilated cardiomyopathy	0.000237	0.00442	CcSEcCtD
Ipratropium bromide—Nausea—Furosemide—dilated cardiomyopathy	0.000236	0.00441	CcSEcCtD
Ipratropium bromide—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000236	0.0044	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00022	0.0041	CcSEcCtD
Ipratropium bromide—Asthenia—Lisinopril—dilated cardiomyopathy	0.000214	0.00399	CcSEcCtD
Ipratropium bromide—Pruritus—Lisinopril—dilated cardiomyopathy	0.000211	0.00394	CcSEcCtD
Ipratropium bromide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000204	0.00381	CcSEcCtD
Ipratropium bromide—Dizziness—Lisinopril—dilated cardiomyopathy	0.000197	0.00368	CcSEcCtD
Ipratropium bromide—Vomiting—Lisinopril—dilated cardiomyopathy	0.00019	0.00354	CcSEcCtD
Ipratropium bromide—Rash—Lisinopril—dilated cardiomyopathy	0.000188	0.00351	CcSEcCtD
Ipratropium bromide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000188	0.00351	CcSEcCtD
Ipratropium bromide—Headache—Lisinopril—dilated cardiomyopathy	0.000187	0.00349	CcSEcCtD
Ipratropium bromide—Nausea—Lisinopril—dilated cardiomyopathy	0.000177	0.00331	CcSEcCtD
Ipratropium bromide—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000115	0.00269	CbGpPWpGaD
Ipratropium bromide—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000115	0.00267	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000115	0.00267	CbGpPWpGaD
Ipratropium bromide—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000114	0.00266	CbGpPWpGaD
Ipratropium bromide—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000113	0.00264	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000111	0.00259	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000111	0.00259	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000111	0.00258	CbGpPWpGaD
Ipratropium bromide—CHRM2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000108	0.00251	CbGpPWpGaD
Ipratropium bromide—CHRM2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000108	0.00251	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000105	0.00245	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000101	0.00236	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000101	0.00235	CbGpPWpGaD
Ipratropium bromide—CHRM1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000101	0.00235	CbGpPWpGaD
Ipratropium bromide—CHRM5—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000101	0.00235	CbGpPWpGaD
Ipratropium bromide—CHRM3—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.0001	0.00234	CbGpPWpGaD
Ipratropium bromide—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.0001	0.00234	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	9.99e-05	0.00233	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	9.63e-05	0.00225	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	9.47e-05	0.00221	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	9.41e-05	0.0022	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	9.38e-05	0.00219	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—AGTR2—dilated cardiomyopathy	9.38e-05	0.00219	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—CXCL2—dilated cardiomyopathy	9.38e-05	0.00219	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	9.29e-05	0.00217	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	9.11e-05	0.00213	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	9.08e-05	0.00212	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	9.01e-05	0.0021	CbGpPWpGaD
Ipratropium bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	9e-05	0.0021	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	9e-05	0.0021	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	8.98e-05	0.0021	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	8.98e-05	0.00209	CbGpPWpGaD
Ipratropium bromide—CHRM1—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	8.89e-05	0.00208	CbGpPWpGaD
Ipratropium bromide—CHRM3—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	8.87e-05	0.00207	CbGpPWpGaD
Ipratropium bromide—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	8.78e-05	0.00205	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—CXCR3—dilated cardiomyopathy	8.72e-05	0.00203	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	8.67e-05	0.00202	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	8.67e-05	0.00202	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	8.64e-05	0.00202	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	8.64e-05	0.00202	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	8.56e-05	0.002	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	8.56e-05	0.002	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—ADRB1—dilated cardiomyopathy	8.44e-05	0.00197	CbGpPWpGaD
Ipratropium bromide—CHRM5—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	8.38e-05	0.00195	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	8.06e-05	0.00188	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	8.04e-05	0.00188	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	7.96e-05	0.00186	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	7.81e-05	0.00182	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	7.78e-05	0.00182	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	7.78e-05	0.00182	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	7.76e-05	0.00181	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	7.71e-05	0.0018	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	7.68e-05	0.00179	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	7.38e-05	0.00172	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	7.36e-05	0.00172	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	7.29e-05	0.0017	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—AGTR1—dilated cardiomyopathy	7.21e-05	0.00168	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	7.14e-05	0.00167	CbGpPWpGaD
Ipratropium bromide—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	7.09e-05	0.00165	CbGpPWpGaD
Ipratropium bromide—CHRM3—G alpha (q) signalling events—AGT—dilated cardiomyopathy	7.06e-05	0.00165	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—ADRB2—dilated cardiomyopathy	6.84e-05	0.0016	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	6.67e-05	0.00156	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	6.66e-05	0.00156	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	6.65e-05	0.00155	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	6.6e-05	0.00154	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	6.6e-05	0.00154	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	6.58e-05	0.00154	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	6.58e-05	0.00154	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	6.58e-05	0.00154	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	6.52e-05	0.00152	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	6.52e-05	0.00152	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ANKRD1—dilated cardiomyopathy	6.38e-05	0.00149	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	6.34e-05	0.00148	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	6.33e-05	0.00148	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	6.32e-05	0.00147	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	6.31e-05	0.00147	CbGpPWpGaD
Ipratropium bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	6.25e-05	0.00146	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	6.25e-05	0.00146	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	6.14e-05	0.00143	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	6.12e-05	0.00143	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	6.06e-05	0.00141	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—TAZ—dilated cardiomyopathy	5.99e-05	0.0014	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	5.95e-05	0.00139	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	5.93e-05	0.00138	CbGpPWpGaD
Ipratropium bromide—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	5.9e-05	0.00138	CbGpPWpGaD
Ipratropium bromide—CHRM3—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	5.88e-05	0.00137	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	5.87e-05	0.00137	CbGpPWpGaD
Ipratropium bromide—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	5.83e-05	0.00136	CbGpPWpGaD
Ipratropium bromide—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	5.82e-05	0.00136	CbGpPWpGaD
Ipratropium bromide—CHRM5—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	5.74e-05	0.00134	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—SDHA—dilated cardiomyopathy	5.42e-05	0.00127	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	5.3e-05	0.00124	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	5.3e-05	0.00124	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	5.08e-05	0.00118	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—AGT—dilated cardiomyopathy	5.08e-05	0.00118	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	5.06e-05	0.00118	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	5.01e-05	0.00117	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	4.93e-05	0.00115	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.82e-05	0.00112	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.81e-05	0.00112	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.81e-05	0.00112	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.8e-05	0.00112	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	4.77e-05	0.00111	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.76e-05	0.00111	CbGpPWpGaD
Ipratropium bromide—SLC22A4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.7e-05	0.0011	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.69e-05	0.00109	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.68e-05	0.00109	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.63e-05	0.00108	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.47e-05	0.00104	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	4.4e-05	0.00103	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	4.38e-05	0.00102	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—ADRB1—dilated cardiomyopathy	4.33e-05	0.00101	CbGpPWpGaD
Ipratropium bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	4.28e-05	0.000999	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.08e-05	0.000951	CbGpPWpGaD
Ipratropium bromide—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	4.04e-05	0.000944	CbGpPWpGaD
Ipratropium bromide—CHRM3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	4.03e-05	0.000941	CbGpPWpGaD
Ipratropium bromide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	3.99e-05	0.000932	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.87e-05	0.000902	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	3.81e-05	0.00089	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.73e-05	0.000871	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.73e-05	0.000871	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.72e-05	0.000868	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.72e-05	0.000868	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.7e-05	0.000864	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.68e-05	0.00086	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.68e-05	0.00086	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	3.66e-05	0.000855	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	3.58e-05	0.000836	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	3.57e-05	0.000834	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—AGT—dilated cardiomyopathy	3.56e-05	0.000831	CbGpPWpGaD
Ipratropium bromide—SLC22A5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.53e-05	0.000824	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	3.53e-05	0.000823	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.51e-05	0.000819	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.47e-05	0.00081	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.46e-05	0.000807	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.42e-05	0.000799	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.39e-05	0.000791	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.39e-05	0.000791	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.38e-05	0.000788	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.38e-05	0.000788	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.36e-05	0.000784	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.35e-05	0.000782	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.35e-05	0.000781	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.35e-05	0.000781	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.32e-05	0.000774	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	3.24e-05	0.000756	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.2e-05	0.000747	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.15e-05	0.000735	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.14e-05	0.000733	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.11e-05	0.000726	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.05e-05	0.000712	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.04e-05	0.00071	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	3.02e-05	0.000704	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.01e-05	0.000703	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	3.01e-05	0.000702	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3e-05	0.0007	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.87e-05	0.00067	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.87e-05	0.000669	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.86e-05	0.000668	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.84e-05	0.000663	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.84e-05	0.000663	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.83e-05	0.000661	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.73e-05	0.000636	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.72e-05	0.000635	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.71e-05	0.000633	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.69e-05	0.000627	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.64e-05	0.000617	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.61e-05	0.000608	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—AGT—dilated cardiomyopathy	2.6e-05	0.000608	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.6e-05	0.000606	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.57e-05	0.0006	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.56e-05	0.000597	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.49e-05	0.000582	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.47e-05	0.000577	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.46e-05	0.000575	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.44e-05	0.000569	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.34e-05	0.000547	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.25e-05	0.000526	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.25e-05	0.000524	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.23e-05	0.000519	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.19e-05	0.00051	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2.12e-05	0.000495	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.11e-05	0.000493	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.11e-05	0.000492	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.09e-05	0.000487	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.07e-05	0.000484	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.02e-05	0.000471	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.01e-05	0.00047	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2e-05	0.000467	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2e-05	0.000467	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	2e-05	0.000466	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	2e-05	0.000466	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.99e-05	0.000465	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.98e-05	0.000461	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.98e-05	0.000461	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.92e-05	0.000448	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.91e-05	0.000446	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.89e-05	0.000442	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.86e-05	0.000434	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.86e-05	0.000433	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.84e-05	0.000429	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.83e-05	0.000428	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	1.83e-05	0.000427	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.81e-05	0.000422	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.81e-05	0.000422	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.8e-05	0.000421	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.8e-05	0.000419	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.78e-05	0.000416	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.78e-05	0.000415	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—RAC1—dilated cardiomyopathy	1.61e-05	0.000376	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.54e-05	0.000359	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—AGT—dilated cardiomyopathy	1.54e-05	0.000359	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.53e-05	0.000358	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.52e-05	0.000355	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	1.47e-05	0.000344	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.46e-05	0.000341	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.46e-05	0.00034	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.44e-05	0.000336	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CD36—dilated cardiomyopathy	1.43e-05	0.000335	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—AGT—dilated cardiomyopathy	1.29e-05	0.000301	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.27e-05	0.000297	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.27e-05	0.000296	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.26e-05	0.000293	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.25e-05	0.000293	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.25e-05	0.000292	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.24e-05	0.000289	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.24e-05	0.000289	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.13e-05	0.000265	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.13e-05	0.000264	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.12e-05	0.000261	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	1.08e-05	0.000253	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	1.08e-05	0.000252	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	1.07e-05	0.00025	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—RAF1—dilated cardiomyopathy	1.07e-05	0.000249	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	8.81e-06	0.000205	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.73e-06	0.000204	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.7e-06	0.000203	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.62e-06	0.000201	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	8.58e-06	0.0002	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	7.72e-06	0.00018	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.52e-06	0.000175	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	7.49e-06	0.000175	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	7.42e-06	0.000173	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—EGFR—dilated cardiomyopathy	7.32e-06	0.000171	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	5.76e-06	0.000134	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	5.61e-06	0.000131	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.16e-06	0.00012	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	5.14e-06	0.00012	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	5.09e-06	0.000119	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	5.05e-06	0.000118	CbGpPWpGaD
